NPI: 1316387954 · SAN LEANDRO, CA 94577 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/27/2013
Authorized official WEY, SAM controls 14+ related entities in our dataset. Read more
| Authorized Official | WEY, SAM (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/27/2013 |
Other providers sharing the same authorized official: WEY, SAM
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | CHINO | CA | $4.52M |
| TRAILSTONE DIALYSIS LLC | ONTARIO | CA | $2.63M |
| DVA HEALTHCARE RENAL CARE INC | SAN FRANCISCO | CA | $1.82M |
| NUEVO DIALYSIS LLC | LAGUNA HILLS | CA | $1.57M |
| CAPES DIALYSIS LLC | SEARCY | AR | $1.51M |
| TOTAL RENAL CARE INC | SANTA ROSA | CA | $818K |
| RENAL TREATMENT CENTERS-SOUTHEAST, LP. | GRETNA | LA | $796K |
| TARGHEE DIALYSIS, LLC | CINCINNATI | OH | $514K |
| GREENWOOD DIALYSIS LLC | TULSA | OK | $74K |
| DVA RENAL HEALTHCARE INC | DURHAM | NC | $10K |
| RENAL CENTER OF MOOREFIELD LLC | MOOREFIELD | WV | $8K |
| BLISS DIALYSIS LLC | BROKEN ARROW | OK | $6K |
| VILLAGEHEALTH DM LLC | DENVER | CO | $0.00 |
| SAKDC - DAVITA DIALYSIS PARTNERS LP | FLORESVILLE | TX | $0.00 |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,612 | $1.11M |
| 2019 | 19,478 | $1.07M |
| 2020 | 20,838 | $1.35M |
| 2021 | 16,243 | $1.43M |
| 2022 | 19,873 | $1.45M |
| 2023 | 15,045 | $1.61M |
| 2024 | 14,052 | $1.70M |
| Code | Description | Claims | Bene. Records | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 44,670 | 3,739 | $9.57M |
| A4657 | Syringe, with or without needle, each | 14,287 | 2,896 | $90K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,944 | 1,386 | $13K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,993 | 1,907 | $13K |
| 0250 | 2,114 | 133 | $6K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,583 | 902 | $6K |
| J1756 | Injection, iron sucrose, 1 mg | 8,935 | 2,284 | $5K |
| 90677 | 19 | 19 | $3K | |
| 83970 | 936 | 901 | $3K | |
| 90662 | 49 | 49 | $1K | |
| 90674 | 63 | 63 | $563.44 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 280 | 224 | $184.29 |
| 82728 | 602 | 589 | $109.68 | |
| 85041 | 1,306 | 1,226 | $80.01 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 70 | 70 | $74.47 |
| 83550 | 280 | 275 | $66.35 | |
| 82108 | 66 | 63 | $60.55 | |
| 85048 | 1,243 | 1,175 | $52.52 | |
| 83540 | 674 | 603 | $52.04 | |
| 85045 | 12 | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 15 | 15 | $0.00 |